Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence

Glaucoma, the leading cause of irreversible blindness, affects >70 million people worldwide. Lowering intraocular pressure via topical administration of eye drops is the most common first-line therapy for glaucoma. This treatment paradigm has notoriously high non-adherence rates: ranging from 30%...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar-Rivera, Marcelo, Erudaitius, Dieanira T., Wu, Vincent M., Tantiongloc, Justin C., Kang, Dae Y., Coleman, Todd P., Baxter, Sally L., Weinreb, Robert N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248824/
https://www.ncbi.nlm.nih.gov/pubmed/32366013
http://dx.doi.org/10.3390/s20092570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248824/
https://www.ncbi.nlm.nih.gov/pubmed/32366013
http://dx.doi.org/10.3390/s20092570

Ejemplares similares